872857-72-2

Basic information

• Product Name: 2-bromo-6-methoxy-3,4-dihydronaphthalen-1-yl acetate
• Synonyms: 2-bromo-6-methoxy-3,4-dihydronaphthalen-1-yl acetate
• CAS NO: 872857-72-2
• Molecular Formula: C₁₃H₁₃BrO₃
• Molecular Weight: 297.14452
• Mol File: 872857-72-2.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-bromo-6-methoxy-3,4-dihydronaphthalen-1-yl acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 2-bromo-6-methoxy-3,4-dihydronaphthalen-1-yl acetate(872857-72-2)
• EPA Substance Registry System: 2-bromo-6-methoxy-3,4-dihydronaphthalen-1-yl acetate(872857-72-2)

Safety Data

• Hazardous Substances Data: 872857-72-2(Hazardous Substances Data)

Upstream product

• 20933-24-8 2-bromo-6-methoxy-1-tetralone 
• 108-24-7 acetic anhydride 
• 1078-19-9 6-methoxy-3,4-dihydro-1(2H)-naphthalenone 

Downstream Products

• 1370525-11-3 C₂₁H₂₂O₅ 
• 872857-98-2 2,6-dimethoxy-3-(6-methoxy-1-oxo-1,2,3,4-tetrahydro-naphthalen-2-yl)-benzonitrile 
• 872857-88-0 2,5-DIMETHOXY-3-(6-METHOXY-1-OXO-1,2,3,4-TETRAHYDRO-NAPHTHALENE-2-YL)-BENZONITRILE 
• 872857-74-4 2-(2,4-dimethoxyphenyl)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one 

Relevant articles and documents

FUSED TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES

The present invention discloses novel Fused Tetracyclic Heterocycle Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, A', G, R1, R15, U, V, V', W, W', X, X', Y and Y' are as defined herein. The present invention also discloses compositions comprising at least one Fused Tetracyclic Heterocycle Compound, and methods of using the Fused Tetracyclic Heterocycle Compounds for treating or preventing HCV infection in a patient.

Tetracyclic compounds as estrogen ligands

This invention provides estrogen receptor modulators having the structure: wherein R1, R2, R3, R4, Q, n, R8, R9, R10, and R11 have been defined in the specification; o